• Users Online: 435
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 11  |  Issue : 2  |  Page : 101-108

prevalence of diabetes mellitus in newly detected patients with hepatitis C


1 Department of Gastroenterology, Government Medical College, Srinagar, Jammu and Kashmir, India
2 Department of Medicine and Gastroenterology, Government Medical College, Srinagar, Jammu and Kashmir, India
3 Department of Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India
4 Department of Endocrinology, Government Medical College, Srinagar, Jammu and Kashmir, India

Correspondence Address:
Dr. Nisar A Shah
Department of Medicine and Gastroenterology, Governtment. Medical College, Srinagar, J&K.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JOD.JOD_14_19

Rights and Permissions

Introduction: Hepatitis C, in addition to liver disease, also causes extrahepatic manifestations in almost 35% of patients, resulting in a spectrum of autoimmune conditions. The prevalence of type 2 diabetes has been reported to be more in these patients. There is a compelling reason to believe this because studies have shown an increased prevalence of hepatitis C virus (HCV) in type 2 diabetes mellitus (DM). The study was conceived to find the prevalence of type 2 DM in HCV-positive patients and its relation to genotype. Materials and Methods: This was a hospital-based case-control study, conducted in the Department of Gastroenterology, Government Medical College Srinagar, Jammu and Kashmir, India. All patients with hepatitis C were enrolled and investigated as per the study design. According to the standard protocol already in vogue, the cases were thoroughly investigated which included all base line investigations, GTT, HbA1c and HOMA-IR. However, majority of the controls were subjected to GTT, HbA1c and homeostatic model assessment of insulin resistance (HOMA-IR) only. Results: Among the cases, the mean age was 45.97 ± 11.982 years; 67.14% had genotype 3 and 32.85% had genotype 1. Cases and controls were compared on the basis of fasting blood sugar levels in three different ranges (≤100 mg%, 101–125 mg%, and ≥126 mg%) and a 2-h GTT at three different levels (<140 mg%, 140–199 mg%, and ≥200 mg%). Other parameters of comparison included HbA1c, serum insulin levels, HOMA-IR, body mass index, liver function test, and lipids. Among all these, only the difference in the level of HOMA-IR (<2.5 in 45.71% of cases and 65.71% of controls) was statistically significant (P = 0.0063). On comparing the diabetogenic potential of two genotypes on the basis of fasting blood sugar and a 2-h GTT, genotype 3 was found to be more diabetogenic. Conclusion: Hepatitis C causes 2.1-fold increase in the prevalence of type 2 diabetes in patients without the evidence of chronicity or complications with increased predisposition to genotype 3 over genotype 1.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed140    
    Printed10    
    Emailed0    
    PDF Downloaded42    
    Comments [Add]    

Recommend this journal